Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

C. S. Tse, Edward Vincent Loftus, Jr, Laura E. H. Raffals, A. A. Gossard, Amy Lightner

Research output: Contribution to journalArticle

23 Scopus citations

Fingerprint Dive into the research topics of 'Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences